Valković Toni, Gačić Vedrana, Ivandić Jelena, Petrov Božo, Dobrila-Dintinjana Renata, Dadić-Hero Elizabeta, Načinović-Duletić Antica
University Hospital Centre Rijeka, Clinic of Gynaecology and Obstetrics, Rijeka, Croatia Phone: +0038551421426 E-mail:
Turk J Haematol. 2015 Sep;32(3):234-42. doi: 10.4274/tjh.2013.0173.
Multiple myeloma is a common haematological malignancy and immune dysfunction is the hallmark of the disease. It leads to an increased infection risk, which is still a major cause of mortality. The infection spectrum and characteristics have evolved with the introduction of novel agents. An understanding of risk factors that increase susceptibility to infections is critical in fighting them. This retrospective investigation aimed to establish the incidence and main characteristics of infections in non-transplanted hospitalised myeloma patients in our department over a 3-year period, as well as factors associated with infections.
A total of 240 hospitalised patients with multiple myeloma (120 males and 120 females; average age: 69 years, range: 41-89 years) who were diagnosed or treated in our department from January 2008 to December 2010 were included in this study and their data were retrospectively analysed.
Infections were identified in 17.9% of hospitalised patients. The most common pathogen found was Pseudomonas aeruginosa. The frequency of gram-positive and gram-negative pathogens was similar. In 37.2% of cases, the agent was not isolated. The most common sites of infections were the urinary system and the blood (septicemia). The frequency of infection increased with duration of disease and the rate of reinfection was 41.9%. The patients treated with bortezomib had the highest infection occurrence. Fatal outcome occurred in 9.3% of cases.
The factors associated with infections in this investigation were female sex, 3B clinical stage of disease, increased serum creatinine and ferritin levels, neutropenia, poor general condition, and presence of catheters. Myeloma patients with one or more of these mentioned risk factors should be monitored with particular care in order to decrease the incidence and severity of infective complications.
多发性骨髓瘤是一种常见的血液系统恶性肿瘤,免疫功能障碍是该疾病的标志。它会导致感染风险增加,而感染仍是主要的死亡原因。随着新型药物的引入,感染谱和特征已经发生了变化。了解增加感染易感性的危险因素对于对抗感染至关重要。这项回顾性研究旨在确定我院非移植住院骨髓瘤患者在3年期间感染的发生率和主要特征,以及与感染相关的因素。
本研究纳入了2008年1月至2010年12月在我院确诊或治疗的240例住院多发性骨髓瘤患者(男性120例,女性120例;平均年龄:69岁,范围:41 - 89岁),并对其数据进行回顾性分析。
17.9%的住院患者发生了感染。最常见的病原体是铜绿假单胞菌。革兰氏阳性菌和革兰氏阴性菌病原体的感染频率相似。在37.2%的病例中,病原体未被分离出来。最常见的感染部位是泌尿系统和血液(败血症)。感染频率随疾病持续时间增加,再感染率为41.9%。接受硼替佐米治疗的患者感染发生率最高。9.3%的病例出现了致命结局。
本研究中与感染相关的因素包括女性、疾病的3B临床分期、血清肌酐和铁蛋白水平升高、中性粒细胞减少、一般状况差以及存在导管。具有上述一种或多种危险因素的骨髓瘤患者应特别密切监测,以降低感染并发症的发生率和严重程度。